医药流通体制改革中第三方医药电子商务的应用
发布时间：2019-01-03 06:28
【摘要】：随着我国医药流通体制改革的不断深入,我国第三方医药电子商务在为集中招标采购提供服务的的基础上迅速的发展,以低成本、高效率、高透明度的特点给传统医药流通体制带来了强力冲击。但是其发展与美国相比还有很多的不足。本文旨在通过对美国第三方医药电子服务在各个领域的广度与深度进行研究,为我国第三方医药电子商务未来发展提供参考 本文采用内容分析方法,对1996年到2011年间国内外医药电子商务相关文献进行分析研究；采用实地调研方法,南京海虹医药电子商务行业研究中心进行实地调研并收集大量资料,对我国医药行业应用电子商务所形成的主要的药电子商务的服务进行分析；采用对比研究的方法,对美国同类成熟模式进行比较分析。 研究内容涉及5个方面：(1)我国医药流通领域的现状；(2)政府药品集中招标采购的现状与问题；(3)积极引入第三方医药电子商务所取得成效与不足；(4)国外第三方医药电子商务的现状；(5)国外第三方医药电子商务对我国第三方医药电子商务的启示 研究表明我国第三方医药电子商务虽然为制药企业、医药流通企业及医院,提供了成交撮合、合同管理、网上交易、第三方结算、数据分析等电子商务服务。在此期间积累了近十多年的数据,掌握了大量的医药行业数据,并为行业主管部门提供电子化的监管手段,从一定程度上降低了药品采购的价格。但与美国相比,其提供的服务的深度和广度均不够。这也是其发展至今仍未能真正完全融入医药流通所有环节中的原因之一,第三方医药电子商务在整个行业中的地位,目前还比较边缘化。我国应该学习美国第三方医药电子商务PBM的的先进经验,积极发展我国第三方医药电子商务,使其深入到流通渠道的医保社保,商业保险,生产企业,医院等各个环节中,实现物流,商流,资金流的高速运转,加速流通体制的改革
[Abstract]:With the deepening of the reform of medicine circulation system in our country, the third party medicine electronic commerce in our country develops rapidly on the basis of providing services for centralized bidding and purchasing, with low cost and high efficiency. The characteristics of high transparency bring a strong impact to the traditional medicine circulation system. But its development still has many shortcomings compared with the United States. The purpose of this paper is to study the breadth and depth of third-party pharmaceutical electronic services in the United States in order to provide a reference for the future development of third-party pharmaceutical electronic commerce in China. From 1996 to 2011, domestic and foreign medical electronic commerce related documents were analyzed and studied. By using the field investigation method, Nanjing Haihong Medical Electronic Commerce Industry Research Center carries on the field investigation and collects the massive data, carries on the analysis to the main medicine electronic commerce service which our country medicine profession uses the electronic commerce; A comparative analysis of similar mature models in the United States was carried out by means of comparative study. The research involves five aspects: (1) the current situation in the field of pharmaceutical circulation in China; (2) the current situation and problems of centralized bidding and procurement of government drugs; (3) the achievements and shortcomings of introducing the third party medicine electronic commerce actively; (4) the current situation of foreign third party medicine electronic commerce; (5) the research on the enlightenment of foreign third party medicine electronic commerce to the third party medicine electronic commerce of our country shows that the third party medicine electronic commerce of our country provides the dealmaking for pharmaceutical enterprises, pharmaceutical circulation enterprises and hospitals. Contract management, online trading, third-party settlement, data analysis and other e-commerce services. During this period, more than ten years of data have been accumulated, a large number of pharmaceutical industry data have been grasped, and electronic means of supervision have been provided for the competent departments of the industry, which has reduced the price of drug procurement to a certain extent. But compared with the United States, it provides not enough depth and breadth of service. This is also one of the reasons that its development has not been fully integrated into all the links in the circulation of medicine, and the status of the third party medicine e-commerce in the whole industry is still relatively marginalized at present. Our country should learn from the advanced experience of PBM in third-party pharmaceutical e-commerce in the United States, and actively develop the third-party pharmaceutical e-commerce in China, so that it can penetrate into various links such as health insurance, commercial insurance, production enterprises, hospitals, and so on, in the circulation channels of health insurance, commercial insurance, production enterprises, hospitals, etc. Realize the high speed operation of logistics, commercial flow and capital flow, accelerate the reform of circulation system
【学位授予单位】：黑龙江中医药大学
【学位级别】：硕士
【学位授予年份】：2011
【分类号】：R95
[Abstract]:With the deepening of the reform of medicine circulation system in our country, the third party medicine electronic commerce in our country develops rapidly on the basis of providing services for centralized bidding and purchasing, with low cost and high efficiency. The characteristics of high transparency bring a strong impact to the traditional medicine circulation system. But its development still has many shortcomings compared with the United States. The purpose of this paper is to study the breadth and depth of third-party pharmaceutical electronic services in the United States in order to provide a reference for the future development of third-party pharmaceutical electronic commerce in China. From 1996 to 2011, domestic and foreign medical electronic commerce related documents were analyzed and studied. By using the field investigation method, Nanjing Haihong Medical Electronic Commerce Industry Research Center carries on the field investigation and collects the massive data, carries on the analysis to the main medicine electronic commerce service which our country medicine profession uses the electronic commerce; A comparative analysis of similar mature models in the United States was carried out by means of comparative study. The research involves five aspects: (1) the current situation in the field of pharmaceutical circulation in China; (2) the current situation and problems of centralized bidding and procurement of government drugs; (3) the achievements and shortcomings of introducing the third party medicine electronic commerce actively; (4) the current situation of foreign third party medicine electronic commerce; (5) the research on the enlightenment of foreign third party medicine electronic commerce to the third party medicine electronic commerce of our country shows that the third party medicine electronic commerce of our country provides the dealmaking for pharmaceutical enterprises, pharmaceutical circulation enterprises and hospitals. Contract management, online trading, third-party settlement, data analysis and other e-commerce services. During this period, more than ten years of data have been accumulated, a large number of pharmaceutical industry data have been grasped, and electronic means of supervision have been provided for the competent departments of the industry, which has reduced the price of drug procurement to a certain extent. But compared with the United States, it provides not enough depth and breadth of service. This is also one of the reasons that its development has not been fully integrated into all the links in the circulation of medicine, and the status of the third party medicine e-commerce in the whole industry is still relatively marginalized at present. Our country should learn from the advanced experience of PBM in third-party pharmaceutical e-commerce in the United States, and actively develop the third-party pharmaceutical e-commerce in China, so that it can penetrate into various links such as health insurance, commercial insurance, production enterprises, hospitals, and so on, in the circulation channels of health insurance, commercial insurance, production enterprises, hospitals, etc. Realize the high speed operation of logistics, commercial flow and capital flow, accelerate the reform of circulation system
【学位授予单位】：黑龙江中医药大学
【学位级别】：硕士
【学位授予年份】：2011
【分类号】：R95
【参考文献】
相关期刊论文 前10条
1 李蓓新;B2B是医药电子商务的主流[J];电子商务;2001年03期
2 耿凡;卞鹰;;医药电子商务B2B模式的发展及我国医药产业电子商务发展的策略研究[J];商场现代化;2006年35期
3 王志强;胡大琴;金新政;;我国B2B医药电子商务发展战略研究[J];商场现代化;2008年34期
4 李云;孙利伟;;第三方医药电子商务模式的发展[J];山西医药杂志(下半月刊);2009年06期
5 耿凡;卞鹰;;我国医药第三方电子交易平台的SWOT分析[J];商业时代;2007年19期
6 胡海宁,雷海潮;美国药品利益管理公司的服务内容[J];卫生经济研究;2002年03期
7 吕旭飞;;“欣弗”事件暴露的问题及其对策[J];卫生经济研究;2007年03期
8 牛丽萍;苘英丽;;基于价值链理论的电子商务模式分析[J];现代企业教育;2009年05期
9 陈玉文;李野;范s，
本文编号：2399009
本文链接：https://www.wllwen.com/jingjilunwen/dianzishangwulunwen/2399009.html
